In vivo expression of ganglionic long-term potentiation in superior cervical ganglia from hypertensive aged rats

Neurobiology of Aging

Volumn 31, Issue 5, 2010, Pages 805-812

  Alzoubi, K H ^a   Aleisa, A M ^b   Alkadhi, K A ^c  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

5 HT3 antagonist; Calcineurin; CaMKII; I O curve; Ondansetron

Indexed keywords

CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; SEROTONIN ANTAGONIST;

AGE DISTRIBUTION; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HYPERTENSION; IMMUNOBLOTTING; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; SUPERIOR CERVICAL GANGLION; SYMPATHETIC GANGLION;

AGING; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CALCINEURIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; HYPERTENSION; LONG-TERM POTENTIATION; MALE; ONDANSETRON; PHOSPHORYLATION; RATS; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; SUPERIOR CERVICAL GANGLION;

EID: 77950536544     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.06.007     Document Type: Article

References (45)

1. 3) receptors. J. Physiol. 1996, 496(Pt 2):479-489.
2. Alkadhi K.A., Otoom S.A., Tanner F.L., Sockwell D., Hogan Y.H. Inhibition of ganglionic long-term potentiation decreases blood pressure in spontaneously hypertensive rats. Exp. Biol. Med. (Maywood) 2001, 226:1024-1030.
3. Alkadhi K.A., Alzoubi K.H., Aleisa A.M. Plasticity of synaptic transmission in autonomic ganglia. Prog. Neurobiol. 2005, 75:83-108.
4. Alkadhi K.A., Alzoubi K.H., Aleisa A.M., Tanner F.L., Nimer A.S. Psychosocial stress-induced hypertension results from in vivo expression of long-term potentiation in rat sympathetic ganglia. Neurobiol. Dis. 2005, 20:849-857.
5. Alkadhi K., Alzoubi K. Role of long-term potentiation of sympathetic ganglia (gLTP) in hypertension. Clin. Exp. Hypertens. 2007, 29:267-286.
6. Alonso-deFlorida F., Morales M.A., Minzoni A.A. Modulated long-term potentiation in the cat superior cervical ganglion in vivo. Brain Res. 1991, 544:203-210.
7. Alzoubi K.H., Bedawi A.S., Aleisa A.M., Alkadhi K.A. Hypothyroidism impairs long-term potentiation in sympathetic ganglia: electrophysiologic and molecular studies. J. Neurosci. Res. 2004, 78:393-402.
8. Alzoubi K.H., Aleisa A.M., Alkadhi K.A. Impairment of long-term potentiation in the CA1, but not dentate gyrus, of the hippocampus in Obese Zucker rats: role of calcineurin and phosphorylated CaMKII. J. Mol. Neurosci. 2005, 27:337-346.
9. Alzoubi K.H., Gerges N.Z., Alkadhi K.A. Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: electrophysiological and molecular studies. Exp. Neurol. 2005, 195:330-341.
10. Alzoubi K.H., Aleisa A.M., Alkadhi K.A. Expression of gLTP in sympathetic ganglia from stress-hypertensive rats: molecular evidence. J. Mol. Neurosci. 2008, 35:201-209.
11. Bachoo M., Polosa C. Preganglionic axons from the third thoracic spinal segment fail to induce long-term potentiation in the superior cervical ganglion of the cat. Can. J. Physiol. Pharmacol. 1992, 70(Suppl.):S27-31.
12. Bachoo M., Heppner T., Fiekers J., Polosa C. A role for protein kinase C in long term potentiation of nicotinic transmission in the superior cervical ganglion of the rat. Brain Res. 1992, 585:299-302.
13. Briggs C.A., McAfee D.A. Long-term potentiation at nicotinic synapses in the rat superior cervical ganglion. J. Physiol. 1988, 404:129-144.
14. Briggs C.A., Brown T.H., McAfee D.A. Neurophysiology and pharmacology of long-term potentiation in the rat sympathetic ganglion. J. Physiol. 1985, 359:503-521.
15. Briggs C.A., McAfee D.A., McCaman R.E. Long-term regulation of synaptic acetylcholine release and nicotinic transmission: the role of cyclic AMP. Br. J. Pharmacol. 1988, 93:399-411.
16. Brown T.H., McAfee D.A. Long-term synaptic potentiation in the superior cervical ganglion. Science 1982, 215:1411-1413.
17. Esler M., Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J. Cardiovasc. Pharmacol. 2000, 35:S1-7.
18. Fukunaga K., Miyamoto E. A working model of CaM kinase II activity in hippocampal long-term potentiation and memory. Neurosci. Res. 2000, 38:3-17.
19. Fukunaga K., Muller D., Miyamoto E. CaM kinase II in long-term potentiation. Neurochem. Int. 1996, 28:343-358.
20. Gerges N.Z., Aleisa A.M., Alhaider A.A., Alkadhi K.A. Reduction of elevated arterial blood pressure in obese Zucker rats by inhibition of ganglionic long-term potentiation. Neuropharmacology 2002, 43:1070-1076.
21. Giannattasio C., Ferrari A.U., Mancia G. Alterations in neural cardiovascular control mechanisms with ageing. J. Hypertens. 1994, (Suppl. 12):S13-17.
22. Giese K.P., Fedorov N.B., Filipkowski R.K., Silva A.J. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science 1998, 279:870-873.
23. Hadjiconstantinou M., Potter P.E., Neff N.H. Trans-synaptic modulation via muscarinic receptors of serotonin-containing small intensely fluorescent cells of superior cervical ganglion. J. Neurosci. 1982, 2:1836-1839.
24. Hogan Y.H., Hawkins R., Alkadhi K.A. Adenosine A1 receptor activation inhibits LTP in sympathetic ganglia. Brain Res. 1998, 807:19-28.
25. Johnston D., Wu S. Cellular Neurophysiology of Learning and Memory in Foundations of Cellular Neurophysiology 1995, MIT Press, Cambridge, MA, pp. 441-475.
26. Lledo P.M., Hjelmstad G.O., Mukherji S., Soderling T.R., Malenka R.C., Nicoll R.A. Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11175-11179.
27. Magee J.C., Schofield G.G. Neurotransmission through sympathetic ganglia of spontaneously hypertensive rats. Hypertension 1992, 20:367-373.
28. Malenka R.C., Kauer J.A., Perkel D.J., Mauk M.D., Kelly P.T., Nicoll R.A., Waxham M.N. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 1989, 340:554-557.
29. Marwaha A., Banday A.A., Lokhandwala M.F. Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats. Am. J. Physiol. Renal Physiol. 2004, 286:F451-457.
30. McCarty R. Age-related alterations in sympathetic-adrenal medullary responses to stress. Gerontology 1986, 32:172-183.
31. McNeil J.J., Silagy C.A. Hypertension in the elderly: epidemiology and pathophysiology. Cardiovasc. Drugs Ther. 1991, 4(Suppl. 6):1197-1201.
32. 2+ in bull-frog sympathetic ganglia. J. Physiol. 1991, 435:421-438.
33. 3 receptor-induced increases in calcium levels in individual brain nerve terminals. J. Neurochem. 1996, 67:581-592.
34. Partanen M., Waller S.B., London E.D., Hervonen A. Indices of neurotransmitter synthesis and release in aging sympathetic nervous system. Neurobiol. Aging 1985, 6:227-232.
35. Pettit D.L., Perlman S., Malinow R. Potentiated transmission and prevention of further LTP by increased CaMKII activity in postsynaptic hippocampal slice neurons. Science 1994, 266:1881-1885.
36. Reis D.J., Ross R.A., Joh T.H. Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse. Brain Res. 1977, 136:465-474.
37. Ris L., Godaux E. Synapse specificity of long-term potentiation breaks down with aging. Learn Mem. 2007, 14:185-189.
38. Roberts L.A., Large C.H., Higgins M.J., Stone T.W., O'Shaughnessy C.T., Morris B.J. Increased expression of dendritic mRNA following the induction of long-term potentiation. Brain Res. Mol. Brain Res. 1998, 56:38-44.
39. Roth-Alpermann C., Morris R.G., Korte M., Bonhoeffer T. Homeostatic shutdown of long-term potentiation in the adult hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11039-11044.
40. Schmidt R.E. Age-related sympathetic ganglionic neuropathology: human pathology and animal models. Auton. Neurosci. 2002, 96:63-72.
41. Thomas K.L., Laroche S., Errington M.L., Bliss T.V., Hunt S.P. Spatial and temporal changes in signal transduction pathways during LTP. Neuron 1994, 13:737-745.
42. 2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. Neuron 1995, 15:443-452.
43. (2+)-dependent protein kinase and phosphatase activities controlling synaptic strength. Learn Mem. 1996, 3:170-181.
44. Wu R.L., McKenna D.G., McAfee D.A. Age-related changes in the synaptic plasticity of rat superior cervical ganglia. Brain Res. 1991, 542:324-329.
45. Yang G.A., Koistinaho J. Age-related increase in c-fos expression in the sympathetic neurons of the rat superior cervical ganglion. Brain Res. 1990, 533:338-343.